Infectious Pulmonary Diseases
Objectives - Identify facts and principles about pneumonia and tuberculosis, including causes, classifications, pathogenesis, signs and symptoms, diagnostic testing, treatment, and infection control concerns.
Pneumonia
Pneumonia is a lower respiratory tract infection that inflames the alveoli in one or both lungs. The alveoli may fill with fluid or pus.
| Pattern | Description |
|---|---|
| Lobar pneumonia | Acute inflammation of an entire lobe or lung |
| Bronchopneumonia | Patchy foci of consolidation scattered in one or more lobes of one or both lungs |
High-yield burden and risk points from the source:
- Pneumonia is listed as the 8th leading cause of death in the U.S.
- About 5 million cases occur annually.
- About 1 million hospitalizations occur annually.
- The source lists 50,622 deaths.
- Risk groups include infants and young children, adults over 65, smokers, immunocompromised patients, and patients with recurring respiratory infections.
Pneumonia Causes
| Category | Examples From Source |
|---|---|
| Bacteria | Streptococcus pneumoniae (pneumococcus), Haemophilus influenzae, Legionella pneumonia, Staphylococcus aureus |
| Viruses | Influenza A and B, corona, respiratory syncytial virus (RSV), adenoviruses |
| Fungi | Coccidioides causing coccidioidomycosis or valley fever, Aspergillus causing aspergillosis |
Pneumonia Classification
Classification is based on where pneumonia was acquired. This helps predict the likely cause and determine empiric antimicrobial therapy.
| Classification | Source Definition | Common Pathogens or Notes |
|---|---|---|
| Community-acquired pneumonia (CAP) | Acquired outside the hospital or care facility | Acute typical CAP includes pneumococcus, H. influenzae, and S. aureus. Acute atypical CAP includes Legionella pneumophila, Chlamydia pneumoniae, and viruses. Chronic CAP develops over weeks to months and includes M. tuberculosis and Histoplasma capsulatum. |
| Health care-associated pneumonia (HCAP) | Develops in patients hospitalized in acute care for 2 or more days within the last 90 days, or in a long-term care facility in the last 30 days | History of recent health care exposure matters. |
| Hospital-acquired pneumonia (HAP) | Develops more than 48 hours after hospital admission after CAP is ruled out | Common pathogens include P. aeruginosa, S. aureus including MRSA/MSSA, Klebsiella pneumoniae, and E. coli. |
| Ventilator-associated pneumonia (VAP) | Develops more than 48 to 72 hours after intubation | The endotracheal tube impairs cough, allows microaspiration around the cuff, may develop a bacterial biofilm, allows secretion pooling around the cuff, and impairs mucociliary clearance. |
Pneumonia Pathogenesis
Pneumonia can develop through several routes:
- Inhalation of aerosolized particles from infectious patients, including COVID and TB.
- Aspiration from the oropharynx during sleep or with impaired gag reflex, narcotic use, alcohol intoxication, or stroke.
- Direct introduction into the lower airway, including frequent suctioning.
- Spread from adjacent organs, such as sub-diaphragmatic or liver abscesses.
- Spread through the blood, which is not common, such as right heart bacterial endocarditis or parasitic pneumonias.
- Reactivation of latent infection in immunosuppressed patients, including Pneumocystis jiroveci, M. tuberculosis, and cytomegalovirus.
Pneumonia Clinical Signs
Common clinical signs include:
- Pleuritic chest pain: sudden, intense, sharp, stabbing, or burning pain with inhaling and exhaling
- Dyspnea
- Expectoration and sputum production
- Fever and chills
- Muscle aches and stiffness
- Cough
- GI symptoms: nausea, vomiting, or diarrhea
Pneumonia Diagnosis
Diagnosis can include imaging, lab testing, and lower respiratory tract sampling.
| Category | Examples |
|---|---|
| Imaging studies | Chest x-ray and computerized tomography (CT) |
| Cultures | Sputum, blood, pleural fluid, bronchoscopy, and mini BAL |
| Lab tests | CBC with elevated or low white blood cell counts, Chem 7 for severity, ABG with low oxygenation values, HIV testing if specific infectious agents are suspected, AFB if TB is suspected, blood culture if bacteremia or septicemia is suspected, influenza testing, and RSV testing |
Sputum Testing
Gram stain and culture place the sputum sample in growing media and analyze for growth. This helps determine the type of bacteria causing pneumonia.
Sensitivity testing determines whether a particular antibiotic or antifungal drug is likely to stop growth of the bacteria or fungi causing the infection.
Bronchoscopy and Mini BAL
Bronchoscopy can acquire lower respiratory tract samples when expectorated samples cannot be obtained or are nondiagnostic.
Bronchoscopy sampling methods include:
- Bronchoalveolar lavage (BAL)
- Routine brushing
- Protected specimen brushing
Mini BAL uses a telescoping catheter to sample lower respiratory tract secretions and improve accurate diagnosis of lung infection.
Pneumonia Treatment
Treatment options listed in the source include:
- Antibiotics
- Antivirals
- Antifungals
- Oxygen
- Fluids
- Airway clearance therapy
Tuberculosis
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. It may affect almost any tissue of the body, especially the lungs, and is characterized by tubercles.
Tuberculosis Classification
| Type | Key Point |
|---|---|
| Primary tuberculosis (active) | Symptomatic shortly after exposure |
| Reactivation tuberculosis (latent) | Symptomatic months to years after exposure |
| Endobronchial tuberculosis | Involves the airways and can result from primary or reactivation TB |
| Extrapulmonary tuberculosis | Spread of M. tuberculosis beyond the lung; may spread to any organ through the lymphatic system |
Active vs Latent TB
| Finding | Active TB | Latent TB |
|---|---|---|
| Symptoms | Symptomatic | No symptoms |
| Infectious | Infectious | Not infectious |
| PPD | Positive | Positive |
| IGRA | Positive | Positive |
| AFB | Negative or positive | Negative |
| Imaging | Abnormal imaging | Normal imaging or granulomas |
Tuberculosis Pathophysiology
TB is acquired by inhalation of airborne droplets containing M. tuberculosis.
Most individuals, 85-95% in the source, contain the infection and remain asymptomatic, but remain susceptible to reactivation later in life or if immunosuppressed.
The immune response produces a tubercle or caseous granuloma made of mononuclear cells and living TB, surrounded by white blood cells and fibroblasts that wall off the organism.
If the immune system cannot stop the infection:
- The organism continues to multiply.
- The center of the granuloma undergoes liquefaction called caseation.
- M. tuberculosis can escape the granuloma and infect other portions of the lungs.
Caseous necrosis is cellular death that usually occurs in the lungs. The dead lung cells develop a crumbly, dull white appearance that resembles cheese.
Tuberculosis Symptoms
Symptoms listed in the source include:
- Cough for at least 3 weeks
- Barking cough
- Hemoptysis
- Fever
- Weight loss
- Night sweats
- Fatigue
- Chest pain
Tuberculosis Diagnosis
Diagnosis can include:
- Patient clinical history and assessment
- Chest x-ray
- TB skin test using tuberculin purified protein derivative (PPD)
- Acid-fast bacilli smear or sputum cultures (AFB)
- Nucleic acid amplification test (NAAT), which detects genetic components of M. tuberculosis and is faster than AFB, less than 24 hours
- Blood tests using interferon gamma release assay (IGRA)
Sputum samples are collected in the morning on 3 consecutive days. If the patient cannot produce sputum, induced sputum or bronchoscopy may be performed.
Tuberculosis Treatment
Treatment lasts 6 to 12 months in the source.
| Medication | Source Note |
|---|---|
| Pyrazinamide | Bactericide |
| Ethambutol | Bacteriostatic; stops reproduction |
| Rifampin | Bactericide |
| Isoniazide | Bactericide and bacteriostatic |
| Streptomycin | Antibiotic |
The Bacille Calmette-Guerin (BCG) vaccination is not used in the U.S. and causes a false positive PPD.
Tuberculosis Infection Control
Hospitalized patients with suspected or confirmed TB must be placed in respiratory isolation and follow airborne precautions.
Required precautions include:
- Private room
- Negative pressure
- N95 masks for room entry
- Proper N95 fit
- Surgical mask for infected patients transported through the hospital
N95 designation means the respirator blocks at least 95% of 0.3 micron test particles if properly fitted.
High-Yield Review
| Topic | High-yield point |
|---|---|
| Pneumonia definition | Lower respiratory tract infection that inflames alveoli, which may fill with fluid or pus |
| CAP vs HAP | CAP is community acquired; HAP develops more than 48 hours after hospital admission after CAP is ruled out |
| VAP | More than 48-72 hours after intubation; ETT impairs cough and permits microaspiration and biofilm formation |
| Pneumonia diagnosis | Imaging, cultures, labs, bronchoscopy, and mini BAL may be used |
| TB spread | Inhalation of airborne droplets containing M. tuberculosis |
| Active TB | Symptomatic, infectious, positive PPD and IGRA, abnormal imaging |
| Latent TB | No symptoms, not infectious, positive PPD and IGRA, AFB negative |
| TB precautions | Private negative-pressure room and N95 mask for room entry |